Search Results - "Bolli, E"

Surface modifications of biodegradable AZ31 alloy after immersion in physiological solution by Ambrogi, V., Bolli, E., Ceccarelli, M., Kaciulis, S., Mezzi, A., Montanari, R., Pakhomova, E., Richetta, M., Varone, A.

“…Internal prosthesis and grafts are currently made of Ti alloys, stainless steels and Co–Cr alloys. In spite of excellent biocompatibility, they show some…”
Get full text

Fluorescence enhancement induced by the interaction of silver nanoclusters with lead ions in water by Burratti, L., Ciotta, E., Bolli, E., Kaciulis, S., Casalboni, M., De Matteis, F., Garzón-Manjón, A., Scheu, C., Pizzoferrato, R., Prosposito, P.

“…[Display omitted] We have synthesized fluorescent and stable silver nanoclusters (AgNCs) capped with poly (methacrylic acid), PMAA, by UV irradiation process…”
Get full text

Adsorption of heavy metals by layered double hydroxides grown in situ on Al foam by Kaciulis, S., Bolli, E., Varone, A., Richetta, M., Narducci, R., Di Vona, M.L., Ciotta, E., Pizzoferrato, R.

“…We investigated the adsorption of heavy metal ions on a nanostructured coating of zinc‐aluminum layered double hydroxides (Zn‐Al LDHs) grown on aluminum foam…”
Get full text

295 Cyclooxygenase-2 (COX2) gene silencing with siRNA could enhance DNA vaccination to inhibit established ErbB-2 carcinomas by Bolli, E, Macagno, M, Arigoni, M, Marchini, C, Amici, A, Forni, G, Cavallo, F

Get full text

Surface characteristics and tribological behavior of 3D-printed 316 L steel after plasma assisted low temperature carburizing by Bolli, E., Kaciulis, S., Lanzutti, A., Mezzi, A., Montanari, R., Palombi, A., Sordetti, F., Vaglio, E., Varone, A., Verona, C.

“…Conventional carburizing treatments of steels are usually carried out above 550 °C thus they are not suitable for austenitic stainless steels because surface…”
Get full text

289 Indoleamine 2,3-Dioxygenase (IDO) silencing for improved antitumour vaccination by Macagno, M, Bolli, E, Marchini, C, Amici, A, Riganti, C, Bosia, A, Forni, G, Cavallo, F

Get full text

Schedule-selective biochemical modulation of 5-fluorouracil: a phase II study in advanced colorectal cancer by SOBRERO, A. F, ASCHELE, C, BRUZZI, P, BERTINO, J. R, GUGLIELMI, A. P, MORI, A. M, TIXI, L. M, BOLLI, E. A, ROSSO, R, MAMMOLITI, S, ROLLANDI, G. A, BERTOGLIO, S

“…Based on experimental findings suggesting that 5-fluorouracil (FUra) may have different mechanisms of action depending on the schedule of administration, we…”
Get full text

Two-dimensional periodic surface nanotexturing of 6H-SiC by ultrashort laser pulses by Mastellone, M., Bolli, E., Valentini, V., Bellucci, A., Orlando, S., Santagata, A., Polini, R., Lettino, A., Sani, E., Trucchi, D.M.

“…Circularly polarized femtosecond laser pulses have successfully promoted the formation of Two-Dimensional Laser Induced Periodic Surface Structures (2D-LIPSS)…”
Get full text

Antitumor immunization of mothers delays tumor development in cancer-prone offspring by Barutello, Giuseppina, Curcio, Claudia, Spadaro, Michela, Arigoni, Maddalena, Trovato, Rosalinda, Bolli, Elisabetta, Zheng, Yujuan, Ria, Francesco, Quaglino, Elena, Iezzi, Manuela, Riccardo, Federica, Holmgren, Lars, Forni, Guido, Cavallo, Federica

“…Maternal immunization is successfully applied against some life-threatening infectious diseases as it can protect the mother and her offspring through the…”
Get full text

Phase II trial of 5-fluorouracil and the natural l isomer of folinic acid in the treatment of advanced colorectal carcinoma by Rosso, R, Mazzei, T, Sobrero, A, Mini, E, Cartei, G, Conte, P, Labianca, R, Cartei, F, Falcone, A, Pancera, G

“…Between February 1991 and July 1992, 79 previously untreated patients with metastatic colorectal carcinoma were enrolled in a phase II study of combined…”
Get more information

5-fluorouracil plus 5-methyltetrahydrofolate in advanced pancreatic cancer by BOLLI, E, SACCOMANNO, S, TIXI, L, PUGLIESE, V, MONDINI, G, ASCHELE, C, GUGLIELMI, A, LIGAS, B, CONNIO, M, MORI, A, ROSSO, R, SOBRERO, A

Get full text

Dacarbazine and fotemustine in advanced colorectal cancer by Tixi, L, Bolli, E, Guglielmi, A, Mori, A, Aschele, C, Nobile, M T, Rosso, R, Sobrero, A

Get more information

Phase II study of 5-fluorouracil plus leucovorin and interferon alpha 2b in advanced colorectal cancer by Sobrero, A, Nobile, M T, Guglielmi, A, Mori, A, Aschele, C, Bolli, E, Tixi, L, Gallo, L, Parodi, G C, Bruzzi, P

“…15 untreated patients with advanced measurable colorectal cancer along with other 29 patients in progression after failing first line chemotherapy with…”
Get more information

Dendritic cell (DC) antitumor vaccine: TEM8 expression in matured DC identifies clinical responders by Venanzi, F., Riccobon, A., Gabrielli, F., Petrini, M., Fiammenghi, L., Granato, A. M., Bolli, E., Ridolfi, L., Concetti, A., Ridolfi, R.

“…Abstract only…”
Get full text

Activity of continuous-infusion 5-fluorouracil in patients with advanced colorectal cancer clinically resistant to bolus 5-fluorouracil by MORI, A, BERTOGLIO, S, GUGLIELMI, A, ASCHELE, C, BOLLI, E, TIXI, L, ROSSO, R, SOBRERO, A

“…We have recently demonstrated that continuous-infusion (CI) 5-fluorouracil (FU) eradicates human colon carcinoma cells made resistant to bolus FU in vitro. In…”
Get full text

305 Circumvention of resistance to 5-fluorouracil by schedule-oriented biochemical modulation in advanced colon cancer patients by Sobrero, A., Aschele, C., Guglielmi, A., Mori, A., Tixi, L., Bolli, E., Grossi, F.

“…We have recently demonstrated that bolus FUra treatments of human colon carcinoma cells, HCT-8, produce resistance via an RNA-related mechanism, while…”
Get full text

5-Fluorouracil plus 5-methyltetrahydrofolate in advanced pancreatic cancer. GLISP (Gruppo Ligure Studio Pancreas) by Bolli, E, Saccomanno, S, Mondini, G, Aschele, C, Guglielmi, A, Ligas, B, Connio, M, Mori, A, Rosso, R, Sobrero, A

“…A total of 20 patients with advanced pancreatic adenocarcinoma were enrolled in a phase II trial testing the activity of 5-fluorouracil given at 370 mg/m2 as a…”
Get full text

Standard indication of immunotherapy for the treatment of cancer by Bolli, E, Tixi, L, Mori, A, Guglielmi, A, Aschele, C, Rovini, E, Sobrero, A

Get more information

Cell resistance in oncology. Therapeutic prospects by Rosso, R, Guglielmi, A, Aschele, C, Mori, A, Tixi, L, Bolli, E, Sobrero, A

Get more information